- Facultat de Medicina
Centre
![Foto de Alberto](/img/nophoto.png)
Alberto
Ortiz Arduan
Publicacions en què col·labora amb Alberto Ortiz Arduan (24)
2024
-
Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations
Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565
-
Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men
Clinical Kidney Journal, Vol. 17, Núm. 1
-
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease
Clinical Kidney Journal, Vol. 17, Núm. 3
2023
-
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25
-
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455
2021
-
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (Drugs, (2021), 81, 13, (1467-1489), 10.1007/s40265-021-01555-5)
Drugs
-
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
Drugs, Vol. 81, Núm. 13, pp. 1467-1489
-
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257
-
Intravenous iron therapy and the cardiovascular system: risks and benefits
Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1067-1076
-
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
Nefrologia, Vol. 41, Núm. 6, pp. 652-660
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
IL‐17A as a potential therapeutic target for patients on peritoneal dialysis
Biomolecules, Vol. 10, Núm. 10, pp. 1-36
-
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease
Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 2026-2042
2019
-
Atherosclerosis in chronic kidney disease: More, less, or just different?
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 10, pp. 1938-1966
-
Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)
Nature Reviews Nephrology
2018
-
Association of FGF-2 concentrations with atheroma progression in chronic kidney disease patients
Clinical Journal of the American Society of Nephrology, Vol. 13, Núm. 4, pp. 577-584
-
Lipid management in patients with chronic kidney disease
Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749
2017
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
2015
-
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185
-
Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development
PLoS ONE, Vol. 10, Núm. 8